- Report
- June 2025
- 26 Pages
Global
From €2620EUR$2,950USD£2,283GBP
- Report
- July 2025
- 86 Pages
Global
From €4437EUR$4,995USD£3,866GBP
- Report
- October 2025
- 160 Pages
Global
From €2982EUR$3,358USD£2,598GBP
€3509EUR$3,950USD£3,057GBP
- Report
- November 2025
- 99 Pages
Global
From €3500EUR$4,221USD£3,156GBP
- Training
- October 2026
- 2 Days
Global
€1543EUR$1,798USD£1,299GBP
€1781EUR$2,075USD£1,499GBP
- Training
- October 2026
- 2 Days
Global
€1543EUR$1,798USD£1,299GBP
€1781EUR$2,075USD£1,499GBP
- Report
- November 2025
- 102 Pages
Global
From €3065EUR$3,450USD£2,670GBP
- Report
- July 2025
- 150 Pages
Global
From €4308EUR$4,850USD£3,753GBP
- Report
- March 2026
Africa, Middle East
From €4263EUR$4,799USD£3,714GBP
- Report
- December 2025
- 162 Pages
United States
From €5285EUR$5,950USD£4,605GBP
- Report
- November 2025
- 37 Pages
Asia Pacific
From €2887EUR$3,250USD£2,515GBP
- Report
- November 2025
- 92 Pages
Europe
From €3509EUR$3,950USD£3,057GBP
- Report
- October 2025
- 93 Pages
Middle East, Oman
From €4308EUR$4,850USD£3,753GBP
From €4308EUR$4,850USD£3,753GBP
- Report
- March 2025
- 355 Pages
Global
From €5168EUR$6,021USD£4,350GBP
- Report
- December 2023
- 261 Pages
Global
From €4693EUR$5,468USD£3,950GBP
- Report
- October 2023
- 428 Pages
Global
From €5168EUR$6,021USD£4,350GBP
- Report
- January 2021
- 184 Pages
Global
From €4352EUR$4,899USD£3,791GBP
- Report
- March 2020
- 210 Pages
China
From €4352EUR$4,899USD£3,791GBP
- Report
- January 2020
- 473 Pages
Global
From €4352EUR$4,899USD£3,791GBP

Contract Manufacturing Organizations (CMOs) are companies that provide manufacturing services to the pharmaceutical industry. CMOs specialize in the production of active pharmaceutical ingredients (APIs) and finished dosage forms (FDFs). They provide a range of services, from process development and scale-up to commercial manufacturing and packaging. CMOs are an important part of the pharmaceutical supply chain, as they enable drug companies to outsource production and focus on their core competencies.
CMOs are subject to stringent regulatory requirements, and must adhere to Good Manufacturing Practices (GMPs) to ensure the quality and safety of their products. They must also comply with the regulations of the countries in which they operate.
CMOs offer a range of advantages to drug companies, including cost savings, access to specialized expertise, and flexibility in production. They also provide a way for drug companies to quickly scale up production to meet demand.
Some of the leading CMOs in the pharmaceutical manufacturing market include Lonza, Boehringer Ingelheim, Patheon, and Recipharm. Show Less Read more